PDCD1 and neoplasm: Surprisingly, this protection was not conferred by the classical PD-1/PD-L1 pathway and the associated inhibitory PD-1 signalling, but rather by PD-L1 itself, whose intracellular domain provided anti-apoptotic signals in tumor cells following engagement by PD-1.